| Literature DB >> 27941865 |
Tian-Xiao Li1, Ming-Hua Yang1, Ying Wang1, Xiao-Bing Wang1, Jun Luo1, Jian-Guang Luo1, Ling-Yi Kong1.
Abstract
The research on secondary metabolites of Aspergillus lentulus afforded eight unusual heterodimeric tetrahydroxanthone derivatives, lentulins A-H (2-9), along with the known compound neosartorin (1). Compounds 1-6 exhibited potent antimicrobial activities especially against methicillin-resistant Staphylococci. Their absolute configurations, particularly the axial chiralities, were unambiguously demonstrated by a combination of electronic circular dichroism (ECD), Rh2(OCOCF3)4-induced ECD experiments, modified Mosher methods, and chemical conversions. Interestingly, compounds 1-4 were the first samples of atropisomers within the dimeric tetrahydroxanthone class. Further investigation of the relationships between their axial chiralities and ECD Cotton effects led to the proposal of a specific CD Exciton Chirality rule to determine the axial chiralities in dimeric tetrahydroxanthones and their derivatives.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27941865 PMCID: PMC5150534 DOI: 10.1038/srep38958
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures and biogenesis relationships of 1–9.
Figure 2Selected HMBC correlations of 2 and 5.
Figure 3Key ROESY correlations of 1–3.
Figure 4ECD spectra of 1–4 (in MeOH).
Figure 5Chemical conversions of 1 and 3.
Figure 6Chemical Conversion of 7 into 5.
Figure 7ΔδH( values of MPA esters for 8 and 9.
Figure 8CD Exciton Chiralities of 1–4.
Figure 9CD Exciton Chiralities of 5–9.
MIC values (μg/mL) of compounds against a panel of bacteria.
| Compound | MRSA | MRSE | |||||
|---|---|---|---|---|---|---|---|
| 6.8 ± 0.6 | >100 | 38.5 ± 4.3 | 31.5 ± 3.7 | >100 | 62.8 ± 4.0 | 63.2 ± 6.3 | |
| 4.7 ± 0.6 | 84.1 ± 9.9 | 65.8 ± 3.9 | 65.7 ± 6.0 | 35.8 ± 4.5 | >100 | >100 | |
| 5.5 ± 0.4 | 3.1 ± 0.3 | 29.3 ± 2.3 | 31.3 ± 3.4 | 8.0 ± 0.6 | 59.1 ± 5.1 | 60.1 ± 4.2 | |
| 13.3 ± 1.5 | >100 | 62.5 ± 5.3 | >100 | >100 | >100 | >100 | |
| 10.6 ± 0.4 | 40.2 ± 0.9 | >100 | >100 | 19.3 ± 0.6 | >100 | >100 | |
| penicillin | 0.5 ± 0.05 | 71.2 ± 6.0 | |||||
| streptomycin | 0.6 ± 0.03 | ||||||
| tigecycline | 0.5 ± 0.03 | 0.7 ± 0.04 | 0.5 ± 0.05 | 0.6 ± 0.03 |
aThe compounds were inactive when MICs > 100 μg/mL, ±SD values were calculated on three individual experiments.
bPositive control.
cSa1, Staphylococcus aureus ATCC 25923; Sa2, S. aureus clinical strain; Pa, Pseudomonas aeruginosa ATCC 9027; Kp, Klebsiella pneumonia clinical strain; Ab, Acinetobacter baumannii clinical strain.